STOCK TITAN

Z Squared (Nasdaq: ZSQR) debuts after transformative Coeptis merger

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Coeptis Therapeutics Holdings, Inc. filed an 8-K announcing it has completed its business combination with Z Squared Inc. and the combined company has been renamed Z Squared Inc.

The company’s public shares are expected to begin trading on the Nasdaq Global Market under the new ticker symbol “ZSQR” on April 27, 2026. Following the transaction, Z Squared Opco Inc. became a wholly owned subsidiary, and former Z Squared Opco stockholders now own about 85% of the combined company, while legacy Coeptis stockholders own about 15%, with roughly 51.5 million common shares outstanding.

Positive

  • None.

Negative

  • None.

Insights

Coeptis completes reverse-style merger, ceding control to Z Squared holders.

Coeptis has closed its business combination with Z Squared, rebranding as Z Squared Inc. and shifting its listing to the Nasdaq Global Market under ticker ZSQR. This effectively replaces Coeptis’s prior profile with a computing infrastructure business.

The ownership mix is heavily skewed: former Z Squared Opco holders now own about 85% of roughly 51.5 million outstanding shares, while pre-transaction Coeptis stockholders hold about 15%. That signals a change of control and substantial dilution for legacy holders.

Coeptis also distributed an interest in a subsidiary holding part of its pre-transaction biopharmaceutical business to record-date stockholders before closing. Future company filings may further detail financials and how the new computing-focused business performs post-combination.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Post-merger shares outstanding 51.5 million shares Common stock issued and outstanding after business combination
Ownership by former Z Squared Opco holders 85% Post-combination ownership of the company
Ownership by legacy Coeptis holders 15% Post-combination ownership of the company
New ticker symbol ZSQR Expected Nasdaq Global Market symbol from April 27, 2026
Trading market Nasdaq Global Market Listing venue for Z Squared Inc. shares
Form type enabling closing Form S-4 effectiveness SEC effectiveness was a closing condition for the business combination
business combination financial
"announced the completion of its business combination with Coeptis Therapeutics Holdings, Inc."
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.
Nasdaq Global Market market
"public shares are expected to commence trading on the Nasdaq Global Market under the ticker symbol"
The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.
pro rata distribution financial
"Coeptis declared and effected a pro rata distribution to Coeptis’s record date stockholders"
A pro rata distribution is when a company or organization shares out money, assets, or benefits evenly among all eligible people based on their size or share. For example, if a company makes a profit and distributes it to shareholders, each person gets a portion proportional to how many shares they own. It ensures everyone gets their fair part based on their ownership or stake.
Form S-4 regulatory
"including SEC effectiveness of the Form S-4 registration statement and the receipt of approval"
A Form S-4 is a legal document that companies file with the government to announce and explain a major business move, such as a merger or acquisition. It provides detailed information to help investors understand how the deal might affect the company's value and future prospects, similar to a detailed blueprint that clarifies the impact of a significant change.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
vertically integrated computing infrastructure technical
"Z Squared, Inc. (Nasdaq: ZSQR) ... a vertically integrated computing infrastructure company"
false 0001759186 0001759186 2026-04-24 2026-04-24 0001759186 us-gaap:CommonStockMember 2026-04-24 2026-04-24 0001759186 us-gaap:WarrantMember 2026-04-24 2026-04-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): April 24, 2026

_____________________

 

COEPTIS THERAPEUTICS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-39669 98-1465952

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

     

105 Bradford Rd, Suite 420

Wexford, Pennsylvania

  15090
(Address of principal executive offices)   (Zip Code)

 

724-934-6467

(Registrant’s telephone number, including area code)

 

____________________________________________________________

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.0001 per share

 

COEP

 
 

Nasdaq Capital Market

Warrants, each whole warrant exercisable for one-half of one share of Common Stock for $230.00 per whole share

 

COEPW

 

Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company     

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      

 

 

   
 

 

 

Item 7.01 Regulation FD Disclosure

 

On April 24, 2026, Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis”) issued a press release (the “Press Release”) announcing that it had completed its business combination with Z Squared Inc. (“Z Squared”) and that its public shares are expected to commence trading on the Nasdaq Global Market under the ticker symbol “ZSQR” on Monday, April 27, 2026 (CUSIP: 98878K108). A copy of the Press Release is furnished as Exhibit 99.1 and incorporated herein by reference.

 

The Press Release is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No. Description

 

99.1 Press Release, dated April 24, 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Coeptis Therapeutics Holdings, Inc.
     
Date: April 24, 2026 By: /s/ David Halabu
   

David Halabu

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

Exhibit 99.1

 

Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market

 

~ Shares to Commence Trading on the Nasdaq Global Market Under Ticker Symbol “ZSQR” Monday April 27, 2026 ~

 

 

 

Fort Lauderdale, FL., April 24, 2026 Z Squared, Inc. (Nasdaq: ZSQR) (“Z Squared” or the “Company”), a vertically integrated computing infrastructure company, today announced the completion of its business combination with Coeptis Therapeutics Holdings, Inc. (“Coeptis”). In connection with the business combination, the combined company has been renamed “Z Squared Inc.” and its public shares are expected to commence trading on the Nasdaq Global Market under the ticker symbol “ZSQR” on Monday, April 27, 2026 (CUSIP: 98878K108).

 

The closing follows the satisfaction of all conditions, including SEC effectiveness of the Form S-4 registration statement and the receipt of approval from Coeptis’ stockholders. In connection with the consummation of the business combination, Z Squared Opco Inc. (formerly Z Squared, Inc.) has become a wholly owned subsidiary of the Company.

 

Prior to the consummation of the business combination Coeptis declared and effected a pro rata distribution to Coeptis’s record date stockholders of Coeptis’s ownership interest in its subsidiary that held a portion of Coeptis’s pre-business combination biopharmaceutical business.

 

In connection with the business combination, the former stockholders of Z Squared Opco Inc. (“Z Squared Opco”) exchanged their shares of Z Squared Opco common stock for shares of common stock of the Company. Following the business combination, the Company has approximately 51.5 million shares of common stock issued and outstanding, with the former stockholders of Z Squared Opco now owning approximately 85% of the Company, and the existing stockholders of the Company owning approximately 15% of the Company.

 

Michelle Burke, Chief Operating Officer commented, “We have built a vertically integrated computing infrastructure platform across three states, supported by dynamic power management, real time analytics, and a comprehensive hardware lifecycle program. Z Squared is well positioned to deliver consistent results and to grow into new geographies and workloads. We could not be more excited about what lies ahead. The market timing is exceptional, and we believe the best is yet to come.”

 

 

 

About Z Squared

 

Z Squared is a vertically integrated computing infrastructure company operating advanced computing equipment strategically distributed across North Carolina, South Carolina, and Iowa. The Company manages and optimizes a substantial fleet of specialized computing hardware, supported by dynamic power management strategies, real time analytics dashboards, and a comprehensive in house repair and lifecycle management program designed to maximize hardware efficiency and reduce capital waste.

 

Z Squared’s distributed, facility agnostic infrastructure is purpose built for operational resilience and rapid scalability. The Company’s infrastructure avoids over reliance on any single hosting provider and supports agile redeployment of equipment based on shifting power costs, infrastructure readiness, and uptime performance. Z Squared’s operational model emphasizes efficiency, discipline, and precision execution, grounded in real time analytics integrated through centralized dashboards that aggregate data from facilities, hardware, and internal systems.

 

The Company’s power strategy is designed to respond flexibly to real time grid conditions, including curtailment schedules and seasonal electricity rate fluctuations. By adapting energy consumption in response to pricing signals, Z Squared aims to lower its cost per kilowatt hour while preserving uptime and maximizing operational efficiency. Z Squared’s distributed, facility agnostic structure reduces exposure to localized disruptions such as regulatory shifts or grid instability, and supports rapid scalability into new geographies and emerging computing workloads.

 

The Company is led by an experienced team with deep expertise in large scale computing operations, infrastructure optimization, and power management.

 

For more information, please visit www.zsquaredinc.com.

 

 

 

 1 

 

 

Cautionary Note Regarding Forward Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the expected commencement of trading of the Company's common stock on the Nasdaq Global Market; the Company’s business strategy, operational plans, and growth prospects; the expected benefits of the Company’s vertically integrated computing infrastructure model; the Company’s ability to scale into new geographies and emerging computing workloads; and the Company’s future financial and operational performance.

 

These forward-looking statements are based on management’s current expectations and assumptions and are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others: the Company’s ability to execute its business strategy; competition in the computing infrastructure and digital asset industries; changes in power costs, energy regulation, and grid conditions; hardware availability, pricing, and obsolescence; the Company’s ability to maintain and expand its facility footprint; the volatility of cryptocurrency markets and digital asset values; market, economic, and capital markets conditions; and regulatory developments affecting the Company’s operations. Additional risks and uncertainties are described under the heading “Risk Factors” in the Company’s Registration Statement on Form S-4, as amended, and other filings with the SEC.

 

Except as required by law, the Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances after the date of this press release, whether as a result of new information, future events, or otherwise.

 

 

 

Investor Relations Contact:

ZSQR@mzgroup.us

 

 

 

 

 

 

 

 

 

 

 

 2 

 

FAQ

What did Coeptis Therapeutics (COEP) announce in this 8-K filing?

Coeptis announced it completed its business combination with Z Squared Inc. The combined company is renamed Z Squared Inc., and its public shares are expected to trade on the Nasdaq Global Market under the ticker ZSQR, replacing Coeptis as the listed entity.

When will Z Squared Inc. shares begin trading under ticker ZSQR?

The company expects its public shares to commence trading on the Nasdaq Global Market under ticker ZSQR on Monday, April 27, 2026. This reflects the completed business combination and renaming of Coeptis Therapeutics Holdings, Inc. to Z Squared Inc. following closing.

How is ownership split after the Coeptis and Z Squared business combination?

After the business combination, former Z Squared Opco stockholders own approximately 85% of the combined company’s common stock. Existing Coeptis stockholders own about 15%, with the company reporting roughly 51.5 million shares of common stock issued and outstanding following closing.

How many shares are outstanding for Z Squared Inc. after the merger?

Following the business combination, the company reports approximately 51.5 million shares of common stock issued and outstanding. This total reflects the exchange of Z Squared Opco shares for company common stock and the resulting ownership split between former Z Squared Opco and legacy Coeptis stockholders.

What happened to Coeptis’s biopharmaceutical business in this transaction?

Before completing the business combination, Coeptis declared and effected a pro rata distribution of its ownership interest in a subsidiary that held part of its pre-business combination biopharmaceutical business. That distribution went to Coeptis record-date stockholders, separating that portion from the new computing infrastructure-focused company.

What type of business does Z Squared Inc. operate after the combination?

Z Squared Inc. operates as a vertically integrated computing infrastructure company. It manages advanced computing equipment across North Carolina, South Carolina, and Iowa, emphasizing dynamic power management, real-time analytics dashboards, and in-house hardware lifecycle management to improve efficiency, resilience, and scalability across its distributed facilities.

Filing Exhibits & Attachments

5 documents